Solmeyea

Solmeyea is a Greece-based startup that specializes in utilizing microalgae and CO2 emissions to produce high-value bioproducts with a positive environmental impact. The company's strategic location in south-eastern Europe provides abundant natural sunlight for nine months of the year, enabling it to harness the power of a vertical tubular photobioreactor technology to control the harvesting of microalgae, along with an exclusive phycocyanin purification process. Solmeyea's focus on the indigenous “Chlamydomonas” microalgae strain enables the production of high-value bioproducts. Moreover, the startup collaborates with heavy CO2 emitters to utilize their fumes and enhance the photosynthetic microalgae process. Solmeyea's commitment to creating a positive environmental impact is evident in its production of high-value proteins that meet the increasing demand for pharma and food products while reducing carbon emissions. For every ton of captured CO2, the company is able to generate 150kg of food protein, 40kg of pharmas, 60kg of fish feed proteins, and 50kg of carotenoids, which are essential for anti-aging, sunscreen, and sun-care products. Founded in 2019, Solmeyea operates in the biopharma, biotechnology, and manufacturing industries. As of now, the startup does not have any publicly disclosed investment or investors.